Latest Pfizer Inc News

Unilever won't top $68B bid for GSK consumer healthcare unit

Jan. 19, 2022 14:01 PM EST

LONDON (AP) — Unilever, the maker of Vaseline skin care products and Dove soap, says it won’t increase a 50 billion-pound ($68.2 billion) offer for GlaxoSmithKline’s consumer healthcare unit that was rejected last week. London-based GSK said Saturday that the bid...

Pfizer chief Albert Bourla wins $1 million Genesis Prize

Jan. 19, 2022 01:31 AM EST

JERUSALEM (AP) — Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded on Wednesday the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine. The $1 million award is granted each year to a person...

Israel study: 4th vaccine shows limited results with omicron

Jan. 17, 2022 14:24 PM EST

JERUSALEM (AP) — An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited defense against the omicron variant that is raging around the world. Sheba Hospital last month began administering a fourth vaccine to...

Canada approves Pfizer COVID drug

Jan. 17, 2022 13:22 PM EST

TORONTO (AP) — Canada’s health regulator has approved a pill by Pfizer that treats the effects of COVID-19. Health Canada authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not...

GSK rejects $68b Unilever bid for consumer healthcare unit

Jan. 15, 2022 15:44 PM EST

LONDON (AP) — The pharmaceutical giant GlaxoSmithKline said Saturday it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit, a joint venture it controls in a partnership with Pfizer. The London-based company said in...

Mexico sees fake molnupiravir, 1 week after drug approved

Jan. 14, 2022 19:16 PM EST

MEXICO CITY (AP) — Mexico said Friday it is already seeing black market or fake versions of molnupiravir circulating for sale, just one week after authorities approved the drug to treat those at risk of severe COVID-19. The real medication is produced by U.S. pharmaceutical...

NOT REAL NEWS: A look at what didn't happen this week

Jan. 14, 2022 11:28 AM EST

A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: ___ Experts say Viagra isn’t a known...

Omicron leaves Germany on brink of recession as growth dips

Jan. 14, 2022 07:40 AM EST

FRANKFURT, Germany (AP) — The risk of recession is looming for Germany after Europe’s biggest economy shrank at the end of 2021 and as it faces a bumpy start to this year, with the rapid spread of COVID-19's omicron variant deterring people from shopping and travel and supply bottlenecks...

COVID-19 pill rollout stymied by shortages as omicron rages

Jan. 13, 2022 13:06 PM EST

WASHINGTON (AP) — Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. The problem, in part, is that production is still being...

South Korea gets first supply of Pfizer's COVID-19 pills

Jan. 13, 2022 08:20 AM EST

SEOUL, South Korea (AP) — South Korea on Thursday received its first supply of Pfizer’s antiviral COVID-19 pills to treat patients with mild or moderate symptoms. Health officials have described the Paxlovid pills as a potentially important tool to suppress hospitalizations and...